P10636 |
TAU_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 |
TAU_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10636 |
TAU_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 |
TAU_HUMAN |
Choreiform disorder [ICD-11: 8A01] |
P10636 |
TAU_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P10636 |
TAU_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 |
TAU_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P11473 |
VDR_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
P11473 |
VDR_HUMAN |
Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 |
VDR_HUMAN |
Hyper-parathyroidism [ICD-11: 5A51] |
P11473 |
VDR_HUMAN |
Hypo-parathyroidism [ICD-11: 5A50] |
P11473 |
VDR_HUMAN |
Mineral deficiency [ICD-11: 5B5K] |
P11473 |
VDR_HUMAN |
Psoriasis [ICD-11: EA90] |
P11473 |
VDR_HUMAN |
Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 |
VDR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P11473 |
VDR_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 |
VDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P11473 |
VDR_HUMAN |
Prostate disease [ICD-11: GA91] |
P11473 |
VDR_HUMAN |
Abnormal micturition [ICD-11: MF50] |
P11473 |
VDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 |
VDR_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 |
VDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P27695 |
APEX1_HUMAN |
Retinopathy [ICD-11: 9B71] |
P27695 |
APEX1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 |
APEX1_HUMAN |
Ocular cancer [ICD-11: 2D00-2D07] |
P27695 |
APEX1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P27695 |
APEX1_HUMAN |
Melanoma [ICD-11: 2C30] |
Q96KQ7 |
EHMT2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 |
EHMT2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 |
EHMT2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P25779 |
CYSP_TRYCR |
Parasitic worm infestation [ICD-11: 1F90] |
P25779 |
CYSP_TRYCR |
Malaria [ICD-11: 1F40-1F45] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P10276 |
RARA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10276 |
RARA_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10276 |
RARA_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10276 |
RARA_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P10276 |
RARA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10276 |
RARA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P10276 |
RARA_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P13631 |
RARG_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P13631 |
RARG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P13631 |
RARG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P13631 |
RARG_HUMAN |
Psoriasis [ICD-11: EA90] |
P13631 |
RARG_HUMAN |
Emphysema [ICD-11: CA21] |
P13631 |
RARG_HUMAN |
Muscle calcification/ossification [ICD-11: FB31] |
P55055 |
NR1H2_HUMAN |
Atopic eczema [ICD-11: EA80] |
P55055 |
NR1H2_HUMAN |
Depression [ICD-11: 6A70-6A7Z] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P19793 |
RXRA_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P19793 |
RXRA_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P28702 |
RXRB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P28702 |
RXRB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P28702 |
RXRB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P28702 |
RXRB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P28702 |
RXRB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P28702 |
RXRB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P28702 |
RXRB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P28702 |
RXRB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P28702 |
RXRB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P28702 |
RXRB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P51449 |
RORG_HUMAN |
Autoimmune disease [ICD-11: 4A40-4A45] |
P51449 |
RORG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P51449 |
RORG_HUMAN |
Psoriasis [ICD-11: EA90] |
P51449 |
RORG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P51449 |
RORG_HUMAN |
Crohn disease [ICD-11: DD70] |
P51449 |
RORG_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P51449 |
RORG_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P51449 |
RORG_HUMAN |
Liver cancer [ICD-11: 2C12] |
P51449 |
RORG_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
P10826 |
RARB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P10826 |
RARB_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10826 |
RARB_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |